These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Zhang Y; Oliver JR; Horowitz JD Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310 [TBL] [Abstract][Full Text] [Related]
7. The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonists. Bolli MH; Boss C; Clozel M; Fischli W; Hess P; Weller T Bioorg Med Chem Lett; 2003 Mar; 13(5):955-9. PubMed ID: 12617929 [TBL] [Abstract][Full Text] [Related]
9. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan. Seo B; Lüscher TF Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390 [TBL] [Abstract][Full Text] [Related]
10. Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo. Holm P; Franco-Cereceda A Acta Physiol Scand; 1999 Feb; 165(2):163-8. PubMed ID: 10090327 [TBL] [Abstract][Full Text] [Related]
11. In vitro characterisation of Ro 46-8443, the first non-peptide antagonist selective for the endothelin ETB receptor. Breu V; Clozel M; Burri K; Hirth G; Neidhart W; Ramuz H FEBS Lett; 1996 Mar; 383(1-2):37-41. PubMed ID: 8612786 [TBL] [Abstract][Full Text] [Related]
12. Effects of Ro 47-0203 and PD155080 on the plasma kinetics, receptor binding and vascular effects of endothelin in the pig. Hemsén A; Modin A; Wanecek M; Malmström RE; Weitzberg E Eur J Pharmacol; 1996 Dec; 318(2-3):369-76. PubMed ID: 9016927 [TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor subtypes in small arteries. Studies with FR139317 and bosentan. Takase H; Moreau P; Lüscher TF Hypertension; 1995 Apr; 25(4 Pt 2):739-43. PubMed ID: 7721425 [TBL] [Abstract][Full Text] [Related]
15. Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists. Harada H; Kazami J; Watanuki S; Tsuzuki R; Sudoh K; Fujimori A; Sanagi M; Orita M; Nakahara H; Shimaya J; Tsukamoto S; Tanaka A; Yanagisawa I Bioorg Med Chem; 2001 Nov; 9(11):2955-68. PubMed ID: 11597477 [TBL] [Abstract][Full Text] [Related]
16. Endothelin B receptor-mediated regulation of endothelin-1 content and release in cultured porcine aorta endothelial cell. Sanchez R; MacKenzie A; Farhat N; Nguyen TD; Stewart DJ; Mercier I; Calderone A; Thorin E J Cardiovasc Pharmacol; 2002 May; 39(5):652-9. PubMed ID: 11973408 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of TA-0201, an endothelin receptor antagonist, with recombinant and human prostate endothelin receptors. Takahashi M; Taniguchi T; Tanaka T; Kanamaru H; Okada K; Muramatsu I Eur J Pharmacol; 2003 Apr; 467(1-3):185-9. PubMed ID: 12706473 [TBL] [Abstract][Full Text] [Related]
18. Identification of a region of the human endothelin ETA receptor required for interaction with bosentan. Adachi M; Furuichi Y; Miyamoto C Eur J Pharmacol; 1994 Oct; 269(2):225-34. PubMed ID: 7851498 [TBL] [Abstract][Full Text] [Related]